LYON, France , July 30, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the U.S. Food and Drug Administration's (FDA) Gastroenterology and Urology Devices Panel (GUDP) voted 3 yes, 5 no with 1 abstention on the question of

FDA Inspector Reported no Findings From the Scheduled Facility Audit

Positions Company to Advance on Preparing U.S. Operations in Connection with FDA Advisory Committee Meeting and PMA process

LYON, France , May 28, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, announced that it has entered into definitive agreements with certain institutional investors for a registered direct placement of 3 million of ordinary shares in the form of

LYON, France , May 27, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today provided additional details on key events scheduled as part of the U.S. Food and Drug Administration (FDA) Pre-Market Approval ("PMA") process for its Ablatherm-HIFU device

LYON, France , May 22, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the U.S. Food and Drug Administration (FDA) Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee will review the Pre-Market

Receives Outstanding Poster Designation for Ablatherm-HIFU

- All Time Record High First Quarter Revenue and Positive Operating Income - Highlights Record revenue of EUR 7.8 million for the first quarter 2014, a 31% year-over-year increase First quarter 2014 gross margin up nine points to 46% Second sequential quarter with positive operating income

LYON, France , May 6, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, reported the first Focal One HIFU treatments performed in Germany . The Department of Urology at the Fuerth Hospital , Germany , headed by Dr.

LYON, France , May 1, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its first quarter 2014 results announcement, which will take place on Thursday, May 15, 2014 , before the opening of the market.